Showing results (401-410 of 501) with videos related to

Sort By:
Pageof 51
Annals of Hematology|May 1, 1995
Differential response of human basophils and mast cells to recombinant chemokinesW Füreder, H Agis, H Semper, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1994
Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemiaW Reinisch, M Willheim, M Hilgarth, et al.
The Journal of Allergy and Clinical Immunology|August 1, 1996
Effects of cyclosporin A and FK-506 on stem cell factor-induced histamine secretion and growth of human mast cellsW R Sperr, H Agis, K Czerwenka, et al.
Journal of Leukocyte Biology|May 1, 1997
Immunophenotypic and functional characterization of human tonsillar mast cellsW Füreder, H C Bankl, J Toth, et al.
Cancer Research|November 1, 1988
In vivo effects of recombinant human interleukin 2 on antitumor and antiviral natural immunity in induced or natural murine immunodeficiency statesL D Butler, C P Browne, N K Layman, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1991
Interleukin 4 promotes expression of mast cell ICAM-1 antigenP Valent, D Bevec, D Maurer, et al.
Leukemia & Lymphoma|March 26, 2002
Association of CD38 antigen expression with other prognostic parameters in early stages of chronic lymphocytic leukemiaD Heintel, I Schwarzinger, C Chizzali-Bonfadin, et al.
Leukemia|April 16, 2004
Prognostic significance of molecular staging by PCR-amplification of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma (DLBCL)G Mitterbauer-Hohendanner, C Mannhalter, K Winkler, et al.
Journal of the National Cancer Institute|September 5, 1990
Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of CancerA D Ho, J Thaler, P Stryckmans, et al.
Blood|November 1, 1992
Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor/kit-ligand in long-term cultureP Valent, E Spanblöchl, W R Sperr, et al.
Pageof 51